Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
NCT01008917
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
sorafenib with temsirolimus
Sponsor
University of California, San Francisco
Collaborators
[object Object]